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
agent
The Phenotypic Spectrum of Patients with PHARC Syndrome Due to Variants in ABHD12The Spectrum of Structural and Functional Abnormalities in Female Carriers of Pathogenic Variants in the RPGR GeneWhole-Exome Sequencing in Age-Related Macular Degeneration Identifies Rare Variants in COL8A1, a Component of Bruch's MembraneClinical characteristics and natural history of rho-associated retinitis pigmentosa.Increased High-Density Lipoprotein Levels Associated with Age-Related Macular DegenerationNeovascular age-related macular degeneration without drusen in the fellow eyeVisual Prognosis in USH2A-Associated Retinitis Pigmentosa Is Worse for Patients with Usher Syndrome Type IIa Than for Those with Nonsyndromic Retinitis PigmentosaCLINICAL AND GENETIC CHARACTERISTICS OF MALE PATIENTS WITH RPGR-ASSOCIATED RETINAL DYSTROPHIESCRB1-associated retinal dystrophiesAssociation of Genetic Variants With Response to Anti-Vascular Endothelial Growth Factor Therapy in Age-Related Macular DegenerationStargardt diseaseMacular Dystrophy and Cone-Rod Dystrophy Caused by Mutations in the RP1 GeneX-linked RetinoschisisThe Natural History of Leber Congenital Amaurosis and Cone-Rod Dystrophy Associated with Variants in the GUCY2D GeneGenotypic and Phenotypic Characteristics of CRB1-Associated Retinal DystrophiesComparing the effectiveness and costs of Bevacizumab to Ranibizumab in patients with Diabetic Macular EdemaQuality of life in patients with CRB1-associated retinal dystrophiesComparing the Effectiveness of Bevacizumab to Ranibizumab in Patients with Exudative Age-Related Macular Degeneration. The BRAMD StudyDefining inclusion criteria and endpoints for clinical trials
author
type
label
Carel B Hoyng